20 May 2013
Keywords: merck, drops, hiv, vacc, candidate, fails, demonstrate
Article | 01 October 2007
US drug major Merck & Co says it has discontinued development of its investigational HIV vaccine candidate V520, after it failed ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
1 October 2007
17 May 2013
© 2013 thepharmaletter.com